EVOFEM BIOSCIENCES, INC. (EVFM) Total liabilities 2019–2025
EVOFEM BIOSCIENCES, INC. (EVFM) total liabilities at each fiscal year-end, per SEC filings.
$89.7MFY2025 · since FY2019: $12.7M → $89.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $89.7M | -0.6% |
| FY2024 | $90.3M | +24.6% |
| FY2023 | $72.5M | -25.3% |
| FY2022 | $97.0M | -31.8% |
| FY2021 | $142.1M | +30.8% |
| FY2020 | $108.6M | +758.1% |
| FY2019 | $12.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More EVFM financial trends
EVFM RevenueEVFM Net incomeEVFM Net marginEVFM Gross profitEVFM Gross marginEVFM Operating incomeEVFM Operating marginEVFM Operating cash flowEVFM Free cash flowEVFM Capital expendituresEVFM Return on equityEVFM Stock buybacksEVFM Dividends paidEVFM Total assetsEVFM Shareholders’ equityEVFM overview →